Skip to main content
HEALTH
SCREENING
SERVICES
- DR. HUDSON PHILIP. PHARM.D(PB)
HEALTH SCREENING SERVICE
 Definition
 Objectives
 WHO Screening Recommendations
 Examples of Screening Services
 Role of Pharmacists
 Importance of Health Screening
 Methods of Screening
 Blood Pressure Screening
 BLOOD SUGAR SCREENING
 LUNG FUNCTION SCREENING
 CHOLESTEROL SCREENING
DEFINITION
Health screening services are the Preventive
measures for early detection of diseases or risk
factors that Targets apparently healthy individuals
which Enables timely medical intervention.
OBJECTIVES
 Early disease detection (hypertension, diabetes)
 Identify risk factors (smoking, obesity)
 Promote lifestyle modification
 Reduce morbidity and mortality
WHO SCREENING
RECOMMENDATIONS
 Screening should be scientifically valid (based
on evidence).
 The condition should be important to public
health.
 There should be an acceptable treatment
available.
 Facilities for diagnosis and treatment must be
accessible.
 Screening should be cost-effective and
ethically acceptable
EXAMPLES OF
SCREENING SERVICES
 Blood pressure measurement → Hypertension
detection
 Blood glucose testing → Diabetes screening
 Lipid profile → Hypercholesterolemia
 BMI calculation → Obesity
 Cancer screening → Cervical smear,
mammography, PSA test
 Vision and hearing tests → Sensory impairment
ROLE OF PHARMACISTS
 Conduct basic screening in community
pharmacies.
 Educate patients about risk factors and lifestyle
changes.
 Refer patients to physicians for further
diagnosis/treatment.
 Maintain records for follow-up and continuity of
care
IMPORTANCE OF
HEALTH SCREENING
 Early detection → Identifies diseases before symptoms
appear (e.g., hypertension, diabetes)
 Prevention → Helps reduce risk factors through lifestyle
modification.
 Cost effective
‑ ness → Saves healthcare costs by
preventing complications.
 Improved prognosis → Early treatment improves survival
and quality of life.
 Community awareness → Promotes health education
and responsible health behaviour.
METHODS OF
SCREENING
1. Mass screening
2. Selective (high risk) screening
‑
3. Multiphasic screening
4. Opportunistic screening
5. Case finding
‑
1. Mass Screening
 Large population groups screened
irrespective of risk.
 Example: National immunization or TB
detection campaigns.
 Advantage: Wide coverage.
 Limitation: Expensive, less efficient
2. Selective (High-risk)
Screening
 Focused on individuals with risk factors
(e.g., smokers for lung cancer, obese
patients for diabetes).
 Advantage: More cost-effective and
targeted
 Limitations: Risk of inequity if vulnerable
populations are overlooked.
3. Multiphasic Screening
 Multiple tests conducted at once (e.g., BP, blood sugar,
cholesterol, BMI).
 Saves time and resources.
 Common in community pharmacy health camps
 Advantages: Efficiency, Cost-effective &
Comprehensive health data.
 Limitations: Overload of data, False positives/negatives
& Resource burden.
4. Opportunistic Screening
 Screening performed during routine healthcare
visits.
 Example: Checking BP when a patient comes for
prescription refill.
 Practical and widely used in pharmacies.
 Advantages: Convenient, Cost-effective & Increases
coverage
 Limitations: Unequal coverage & Inconsistent
implementation.
5. Case-finding
 Identifying disease in patients who
present with unrelated complaints.
 Example: Detecting diabetes in a patient
visiting for minor illness
 Advantages: More targeted, Cost-
effective & Improves early diagnosis and
treatment outcomes.
 Limitations: healthcare access & Risk of
under-detection.
Blood Pressure
Screening Methods
1. Manual (Auscultatory) Method
2. Digital (Oscillometric) Method
3. Ambulatory BP Monitoring (ABPM)
4. Home BP Monitoring (HBPM)
5. Community pharmacy camps
1. Manual (Auscultatory)
Method
 Instrument: Mercury sphygmomanometer
or aneroid sphygmomanometer +
stethoscope.
 Procedure:
o Cuff placed on upper arm, inflated
above systolic pressure.
o Slowly deflate while listening at brachial
artery.
o First Korotkoff sound → Systolic BP.
o Disappearance of sound → Diastolic BP.
2. Digital (Oscillometric)
Method
 Instrument: Electronic BP monitor.
 Procedure:
o Cuff inflates/deflates automatically.
o Device detects oscillations in arterial wall.
o Provides systolic, diastolic, and pulse rate
digitally.
 Advantages: Easy to use,
suitable for self screening
‑ .
3. Ambulatory Blood
Pressure Monitoring (ABPM)
 Instrument: Portable device worn for
24 hours.
 Procedure:
o Records BP at intervals during
daily activities and sleep.
o Detects “white coat
hypertension” and nocturnal BP
patterns.
4. Home Blood Pressure
Monitoring (HBPM)
 Instrument: Digital BP monitors for self use.
‑
 Procedure:
o Patients measure BP at home, usually twice
daily.
o Helps in long term monitoring and adherence
‑
5. Community Pharmacy
Screening Camps
 Method: Mass or opportunistic
screening during health camps.
 Procedure:
o BP measured for walk in
‑
patients.
o Records maintained,
referrals made if abnormal
Blood Sugar
Screening Methods
1. Fasting Blood Glucose (FBG)
2. Postprandial Blood Glucose (PPBG)
3. Random Blood Glucose (RBG)
4. Oral Glucose Tolerance Test (OGTT)
5. HbA1c testing
6. Glucometer (POCT)
1. Fasting Blood Glucose
(FBG)
 Procedure: Blood sample
taken after 8–12 hours of fasting.
 Interpretation:
 Normal: <100 mg/dL
 Prediabetes: 100–125 mg/dL
 Diabetes: ≥126 mg/dL
2. Postprandial Blood
Glucose (PPBG)
 Procedure: Blood sample taken 2 hours
after a meal.
 Interpretation:
 Normal: <140 mg/dL
 Diabetes: ≥200 mg/dL
3. Random Blood Glucose
(RBG)
 Procedure: Blood sample taken
at any time, regardless of meals.
 Interpretation:
 ≥200 mg/dL with symptoms →
Suggestive of diabetes.
4. Oral Glucose Tolerance
Test (OGTT)
 Procedure:
 Fasting sample taken.
 Patient consumes 75 g glucose solution.
 Blood sugar measured at 2 hours.
 Interpretation:
 Normal: <140 mg/dL
 Prediabetes: 140–199 mg/dL
 Diabetes: ≥200 mg/dL
5. HbA1c (Glycated
Haemoglobin)
 Procedure: Measures average blood
glucose over 2–3 months.
 Interpretation:
 Normal: <5.7%
 Prediabetes: 5.7–6.4%
 Diabetes: ≥6.5%
6. Point of Care Testing
‑ ‑
(POCT) / Glucometer
 Procedure: Finger prick capillary
‑
blood tested using portable
glucometer.
 Advantages: Quick,
convenient, suitable for
pharmacy and home use
LUNG FUNCTION
SCREENING
1. Spirometry (FEV1, FVC)
2. Peak Expiratory Flow Rate (PEFR)
3. Pulse oximetry (SpO )
₂
4. Chest X ray
‑
5. Questionnaire based screening
‑
1. SPIROMETRY
 Procedure: Patient breathes into a
spirometer; measures lung
volumes and airflow.
 Parameters:
 FEV1 (Forced Expiratory Volume in
1 sec)
 FVC (Forced Vital Capacity)
 FEV1/FVC ratio → distinguishes
obstructive vs restrictive disease.
2. PEAK EXPIRATORY FLOW
RATE (PEFR)
 Instrument: Peak flow meter.
 Procedure: Patient exhales forcefully
into device; measures maximum
airflow.
 Use: Monitoring asthma control,
detecting airway obstruction.
3. PULSE OXIMETRY
 Instrument: Finger clip pulse
‑
oximeter.
 Procedure: Measures oxygen
saturation (SpO ) and pulse rate.
₂
 Use: Detects hypoxemia in COPD,
asthma exacerbations,
pneumonia.
4. CHEST X RAY (BASIC
‑
IMAGING)
 Procedure: Radiographic imaging of
lungs.
 Use: Detects structural abnormalities,
infections, tumours.
5. QUESTIONNAIRE BASED
‑
SCREENING
 Method: Standardized tools (e.g., COPD
Assessment Test, Asthma Control Test).
 Use: Identifies patients at risk who should
undergo spirometry
CHOLESTEROL
SCREENING METHODS
1. Total cholesterol test
2. Lipid profile panel
3. Random cholesterol test
4. Portable cholesterol meters (POCT)
5. Advanced tests (ApoB, Non HDL
‑
cholesterol)
1. TOTAL CHOLESTEROL TEST
 Procedure: Blood sample (fasting or
non fasting).
‑
 Interpretation:
 Desirable: <200 mg/dL
 Borderline: 200–239 mg/dL
 High: ≥240 mg/dL
2. LIPID PROFILE
(COMPREHENSIVE PANEL)
 Procedure: Fasting blood sample (8–12 hours).
 Parameters:
 Total cholesterol
 LDL (Low density lipoprotein)
‑
 HDL (High density lipoprotein)
‑
 Triglycerides
 Interpretation:
 LDL (“bad cholesterol”) should be <100 mg/dL.
 HDL (“good cholesterol”) should be ≥40 mg/dL (men), ≥50 mg/dL
(women).
3. RANDOM (NON FASTING)
‑
CHOLESTEROL TEST
 Procedure: Blood sample taken anytime.
 Use: Quick screening in pharmacy or
health camps
4. POINT OF CARE TESTING (POCT)
‑ ‑
/ PORTABLE CHOLESTEROL METERS
 Procedure: Finger prick capillary blood
‑
tested using portable device.
 Advantages: Quick, convenient, suitable
for pharmacy and home use.
5. ADVANCED TESTS
(CONFIRMATORY / MONITORING)
 Apolipoprotein B (ApoB) → Reflects LDL particle number.
 Non HDL cholesterol
‑ → Total cholesterol minus HDL.
Comprehensive Health Screening Services: Methods, Roles, and Importance